Cost of Heart Failure in Patients Receiving -Blockers and Angiotensin-Converting Enzyme Inhibitors

By Weintraub W.S.  

Clinical Drug Investigation, Vol. 24, Iss. 5, 2004-01 ,pp. : 255-264

Adis International

Access to resources Recommend Favorite

Interaction between angiotensin-converting enzyme inhibitors and aspirin: a review

By Meune C.   Mahe I.   Mourad J.J.   Simoneau G.   Knellwolf A.L.   Bergmann J.F.   Caulin C.  

European Journal of Clinical Pharmacology, Vol. 56, Iss. 9-10, 2000-12 ,pp. : 609-620

Springer Publishing Company

Access to resources Recommend Favorite

Antioxidant and Cardioprotective Properties of the Sulphydryl Angiotensin-converting Enzyme Inhibitor Zofenopril

By Evangelista S   Manzini S  

The Journal of International Medical Research, Vol. 33, Iss. 1, 2005-01 ,pp. : 42-54

Field House Publishing

Access to resources Recommend Favorite

Nitric oxide donors and angiotensin-converting enzyme inhibitors act in concert to inhibit human angiotensin-converting enzyme activity and platelet aggregation in vitro

By Persson K.   Whiss P.A.   Nyhlen K.   Jacobsson-Strier M.   Glindell M.   Andersson R.G.G.  

European Journal of Pharmacology, Vol. 406, Iss. 1, 2000-10 ,pp. : 15-23

Elsevier

Access to resources Recommend Favorite

Angiotensin‐converting enzyme 2–Angiotensin 1‐7/1‐9 system: novel promising targets for heart failure treatment

By  

Fundamental & Clinical Pharmacology, Vol. 32, Iss. 1, 2018-02 ,pp. : 14-25

John Wiley & Sons Inc

Access to resources Recommend Favorite